| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ead9279f7250bb094fdf43c4bfe1324 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-04 |
| filingDate |
1977-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1978-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c69c64f75923922420784e50217c2265 |
| publicationDate |
1978-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4110437-A |
| titleOfInvention |
Method of treating cancerous cachexia in humans with hydrazine sulfate |
| abstract |
Hydrazine sulfate alone or formulated with liquid or solid carriers will retard and reduce cancerous cachexia even in the absence of tumor reduction when administered to humans either orally or parenterally. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02503197-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4867978-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2718733-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8807372-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3018170-A1 |
| priorityDate |
1975-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |